Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Seabirds show signs of avian flu immunity
Northern gannets in the UK seem to have been less affected by avian influenza this year.

Scientists find signs of immunity in shags and northern gannets.

Researchers have found that some seabird species are showing signs of immunity to the H5N1 strain of avian influenza.

Tests conducted on small sample groups of seabirds by the Government-funded FluMap research consortium have found protective antibodies in northern gannets and shags.

Although tens of thousands of wild birds are believed to have died from the virus this year in the UK, these antibodies could explain why some species seem to be less affected by the virus compared to last year.

While in 2022 northern gannets experienced an unusually high mortality rate at their main breeding colony of Bass Rock in Scotland, there were fewer reported deaths this summer.

The findings come at a time when the impact of the outbreak, which first hit the UK in October 2021, seems to be declining. So far this October, there have been no new confirmed cases of the virus in kept birds in the UK.

As part of its research, the FluMap consortium has also mapped the spread of the virus. Researchers found that the virus can only travel short distances of less than 10 metres, suggesting that it is very unlikely that the virus can be spread through airborne transmission between farms.

Following the initial success of the research, the Government has awarded the consortium £3.3 million in additional funding, with the investment coming from UK Research and Innovation’s Tackling Infections programme and the Department for Environment, Food and Rural Affairs.

A further £3.2 million has also been allocated for a sister consortium, which will focus on the potential for human transmission. The two consortia will work together in a One Heath approach

Lord Benyon, biosecurity minister, said: “Bird flu has been devastating on kept and wild birds. This has caused an emotional and financial toll on bird keepers and those who love our wildlife.

“That is why we are continuing to invest in world leading science to improve our understanding of this disease and inform future ways to prevent and control it."

UK chief veterinary officer Christine Middlemiss added: “I am delighted this research project has received further funding. Bringing together all our national experts increases the speed and quality of our understanding of avian influenza and how it behaves in the UK.

“This critical research will aid our development of further strategies to protect our birds and minimise the impact of this dreadful disease.”

Image (C) Shutterstock

Become a member or log in to add this story to your CPD history

Defra shares new Sanitary and Phytosanitary guidance

News Story 1
 Defra has published guidance for the vet sector ahead of a proposed UK-EU Sanitary and Phytosanitary agreement.

The agreement, which will change the movement and trade of animals and related products, could see reductions in checks, paperwork and certification. As well as describing regulatory developments, the advice highlights the importance of animal ID, registration and traceability in disease control and other compliance arrangements.

The guidance can be found here. More detail is expected as negotiations progress. 

Click here for more...
News Shorts
Lords Committee opens Pet Parasite Medication inquiry

The House of Lords Environment and Climate Change Committee will launch its inquiry into Pet Parasite Medication (PPM) on Wednesday (3 June).

Focusing on treatments containing fipronil and imidacloprid, the inquiry will seek to understand distribution pathways and the impacts of PPM use and non-use on biodiversity and human health. It will also cover current regulation, monitoring, and the potential implications for pets and their owners.

The committee will hear evidence from environmental non-governmental organisations and research institutes. The public can follow the proceedings live on Parliament TV or in person in the Palace of Westminster.